alexa Costs And Cost Effectiveness Of New Tools For Diagnosis And Treatment Of Tuberculosis In A Brazilian Hospital Setting
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Clinical Microbiology & Microbial Genomics
September 24-26, 2014 Valencia Convention Centre, Spain

Luciene Cardoso Scherer
Accepted Abstracts: Clin Microbial
DOI: 10.4172/2327-5073.S1.016
Abstract
Recent worldwide data on TB show that Brazil is among the 22 countries that comprise high loads of the disease; it is estimated that these countries concentrate approximately 80% of all new cases in the world. Direct microscopy has low sensitivity for TB diagnosis and cultures take 3 to 6 weeks. According to recent studies, the rate of co-infection of TB/HIV is estimated at 3% to 4%. Therefore, new tools for TB diagnosis are necessary, especially in health settings with a high prevalence of HIV/TB co-infection. In Latin American, some studies have evaluated the costs and cost-effectiveness of new tools for TB diagnosis and treatment (PCR techniques, GenoType? MTBDR, GeneXpert? MTB/RIF) showing the costs of the health system and their families; the costs for patients with MDR-TB; cost-effectiveness analysis for patients with TB in supervised and self-administered treatment. Clinical algorithms can increase the pretest likelihood of TB diagnosis in high and low income countries. Since substantial economic costs are related to unnecessary isolation of patients, a clinical model to predict active TB in patients admitted to hospitals can become an important tool for improving infection control in resource constrained countries with high disease burden. However, in Brazil the real costs of TB until are poorly estimated and the overall costs of TB are not perceived by government entities given the fragmentation of the involvement of all three levels of local, state and federal government levels. In addition, the new tools inside the clinical routine and to make rational decisions about the implementation of new tools the cost-effectiveness studies are essential. In the lecture, author will describe the studies conducted by her group, where the direct and indirect costs for diagnosis and treatment of pulmonary tuberculosis in patients admitted to a Public Health Hospital Unit in Brazil was evaluated and the cost-effectiveness analysis of molecular methods (PCR) for the rapid diagnosis of TB and clinical algorithms to predict active TB in patients admitted in Brazilian hospitals.
Biography
Luciene Cardoso Scherer graduated in Pharmacy from the Universidade Federal do Rio Grande do Sul in 1995, and graduated in Biomedicine from the Universidade Luterana do Brasil in 2009, and received the masters in Biological Sciences (Biochemistry) from the Universidade Federal do Rio Grande do Sul in 2000 and PhD in Biological Sciences (Biochemistry) from the Universidade Federal do Rio Grande do Sul in 2008. Currently, she is a Professor at the Universidade Luterana do Brasil, acting in Biomedicine and Pharmacy graduation courses and in the Post Graduation Program in Public Health. She has experience in the area of Health Technology Assessment. She was accepted by the Tuberculosis Research Unit, in IDT-HUCFF Hospital Complex, in Medical School of Universidade Federal do Rio de Janeiro to do studies in post doctoral program. She has published recently 2 papers in reputed journals and has served as an editorial board member of repute in Health Technology Assessment and in the areas of monitoring and diagnostics of infectious diseases.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords